Abiopharma

🔍 Wong Rich (Executive)

Company: UiPath, Inc. (PATH)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 19,175 shares of Class A Common Stock (Direct)
  Date: 2026-06-25 | Code: A | equity_swap_involved: false | shares_owned_after: 89,663.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 774,831.00 | Footnotes: F3

Footnotes:

• F1: This grant was made pursuant to the issuer's non-employee director compensation policy.
• F2: Includes 19,175 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock upon settlement. Each Annual Director RSU vests on the earlier of the date of the following year's annual meeting (or the date immediately prior to the next annual meeting, if the non-employee director's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election), or the first anniversary of the date of grant, in each case subject to the director's continued service through such vesting date.
• F3: The Reporting Person disclaims Section 16 beneficial ownership over the securities reported herein except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purpose.